Monday, February 18, 2019

Best Clean Energy Stocks To Own Right Now

tags:ARRY,NTRS,JFR, &l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-41782461&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/41782461/960x0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; A wind turbine stands next to solar panels in Japan. Wind and solar are set to provide half of the world&s;s electricity by 2050, says BNEF. Photographer: Buddhika Weerasinghe/Bloomberg

Renewable energy is set to go from strength to strength in coming years and it will be generating 50% of global electricity by 2050, according to one of the most authoritative voices in clean energy.

However, President Trump&a;rsquo;s battle to save the coal industry looks doomed, with coal-powered generation set to make up just 11% of global electricity generation by the middle of the century, down from 38% today, according to Bloomberg New Energy Finance.

Its New Energy Outlook (NEO) 2018 says that the continuing fall in the cost of batteries will massively increase the ability the ability to store off-peak electricity and sell it when demand is high, which will enable renewable technologies &a;ndash; particularly wind and solar projects - to take an increasing share of the electricity market. This will create a $548 billion battery market, with total investment in clean energy between now and 2050 set to reach $11.5 trillion.

Best Clean Energy Stocks To Own Right Now: Array BioPharma Inc.(ARRY)

Advisors' Opinion:
  • [By Max Byerly]

    Swiss National Bank raised its holdings in Array Biopharma Inc (NASDAQ:ARRY) by 5.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 325,600 shares of the biopharmaceutical company’s stock after acquiring an additional 16,900 shares during the quarter. Swiss National Bank’s holdings in Array Biopharma were worth $5,314,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Array Biopharma (ARRY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    It looks like the benefit-to-risk ratio is off the charts for larotrectinib as well as LOXO-292, but the number of patients with TRK fusion cancers that fail multiple existing treatments is somewhere between 1,500 and 5,000 each year in the U.S. Investors also need to understand that Loxo Oncology licensed its candidates from Array Biopharma (NASDAQ:ARRY) and owes its partner substantial milestone payments and mid-single-digit royalties on any sales they might generate. Loxo has partnered with Bayer AG (NASDAQOTH:BAYRY), and if approved, the German giant will share U.S. profits with Loxo and pay double-digit royalties on sales abroad.

Best Clean Energy Stocks To Own Right Now: Northern Trust Corporation(NTRS)

Advisors' Opinion:
  • [By Shane Hupp]

    Independent Bank (NASDAQ: NTRS) and Northern Trust (NASDAQ:NTRS) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership and dividends.

  • [By Ethan Ryder]

    Segall Bryant & Hamill LLC lessened its stake in Northern Trust Co. (NASDAQ:NTRS) by 2.8% during the 1st quarter, Holdings Channel reports. The firm owned 292,157 shares of the asset manager’s stock after selling 8,377 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Northern Trust were worth $30,130,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Silvercrest Asset Management Group LLC decreased its holdings in Northern Trust Co. (NASDAQ:NTRS) by 14.7% in the first quarter, HoldingsChannel reports. The firm owned 18,550 shares of the asset manager’s stock after selling 3,200 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in Northern Trust were worth $1,913,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Northern Trust (NASDAQ:NTRS) declared that its board has initiated a stock repurchase plan, which authorizes the company to repurchase 25,000,000 shares on Tuesday, July 17th. This repurchase authorization authorizes the asset manager to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Best Clean Energy Stocks To Own Right Now: Nuveen Floating Rate Income Fund(JFR)

Advisors' Opinion:
  • [By Max Byerly]

    Swift Run Capital Management LLC lessened its holdings in Nuveen Floating Rate Inc (NYSE:JFR) by 30.4% during the first quarter, Holdings Channel reports. The fund owned 16,000 shares of the company’s stock after selling 7,000 shares during the quarter. Swift Run Capital Management LLC’s holdings in Nuveen Floating Rate were worth $174,000 as of its most recent SEC filing.

No comments:

Post a Comment